Related Experiment Videos
Mitral anular calcification in chronic renal failure
Insights
Mitral annular calcification (MAC) is more common in chronic renal failure patients due to abnormal calcium-phosphorus balance. Controlling hyperphosphatemia is key to preventing MAC in hemodialysis patients.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Mitral annular calcification (MAC) is a cardiovascular complication.
- Chronic renal failure (CRF) patients exhibit unique metabolic derangements.
Purpose of the Study:
- To investigate the incidence and pathogenesis of MAC in patients with chronic renal failure.
- To identify etiological factors and preventive strategies for MAC in hemodialysis patients.
Main Methods:
- Analysis of biochemical, hemodynamic, and echocardiographic data.
- Study cohort comprised 168 patients undergoing long-term hemodialysis.
Main Results:
- MAC is more prevalent in CRF patients compared to age-matched controls.
- Abnormal calcium-phosphorus homeostasis and secondary hyperparathyroidism are implicated in MAC pathogenesis.
- Hypertension was not identified as a significant etiological factor.
Conclusions:
- Abnormal mineral metabolism in CRF contributes to MAC development.
- Effective management of hyperphosphatemia is crucial for preventing MAC in hemodialysis patients.
Abstract:
In order to determine the incidence and pathogenesis of mitral anular calcification (MAC) in chronic renal failure, we analyzed biochemical, hemodynamic and echocardiographic data in 168 patients on long-term hemodialysis. Mitral anular calcification is more common in patients with chronic renal failure than in other patients of similar age. Its pathogenesis appears to be due to abnormal calcium-phosphorus homeostasis in the setting of secondary hyperparathyroidism. Hypertension did not appear to be an important etiologic factor in our patients. Meticulous control of hyperphosphatemia would appear to be the most important therapeutic measure in preventing this complication.